Back to Search Start Over

Elevated LDL Triglycerides and Atherosclerotic Risk

Authors :
Balling, Mie
Afzal, Shoaib
Davey Smith, George
Varbo, Anette
Langsted, Anne
Kamstrup, Pia R.
Nordestgaard, Børge G.
Balling, Mie
Afzal, Shoaib
Davey Smith, George
Varbo, Anette
Langsted, Anne
Kamstrup, Pia R.
Nordestgaard, Børge G.
Source :
Balling , M , Afzal , S , Davey Smith , G , Varbo , A , Langsted , A , Kamstrup , P R & Nordestgaard , B G 2023 , ' Elevated LDL Triglycerides and Atherosclerotic Risk ' , Journal of the American College of Cardiology , vol. 81 , no. 2 , pp. 136-152 .
Publication Year :
2023

Abstract

Background: It is unclear whether elevated low-density lipoprotein (LDL) triglycerides are associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD). Objectives: This study tested the hypothesis that elevated LDL triglycerides are associated with an increased risk of ASCVD and of each ASCVD component individually. Methods: The study investigators used the Copenhagen General Population Study, which measured LDL triglycerides in 38,081 individuals with a direct automated assay (direct LDL triglycerides) and in another 30,208 individuals with nuclear magnetic resonance (NMR) spectroscopy (NMR LDL triglycerides). Meta-analyses aggregated the present findings with previously reported results. Results: During a median follow-up of 3.0 and 9.2 years, respectively, 872 and 5,766 individuals in the 2 cohorts received a diagnosis of ASCVD. Per 0.1 mmol/L (9 mg/dL) higher direct LDL triglycerides, HRs were 1.26 (95% CI: 1.17-1.35) for ASCVD, 1.27 (95% CI: 1.16-1.39) for ischemic heart disease, 1.28 (95% CI: 1.11-1.48) for myocardial infarction, 1.22 (95% CI: 1.08-1.38) for ischemic stroke, and 1.38 (95% CI: 1.21-1.58) for peripheral artery disease. Corresponding HRs for NMR LDL triglycerides were 1.26 (95% CI: 1.20-1.33), 1.33 (95% CI: 1.25-1.41), 1.41 (95% CI: 1.31-1.52), 1.13 (95% CI: 1.05-1.23), and 1.26 (95% CI: 1.10-1.43), respectively. The foregoing results were not entirely statistically explained by apolipoprotein B levels. In meta-analyses for the highest quartile vs the lowest quartile of LDL triglycerides, random-effects risk ratios were 1.50 (95% CI: 1.35-1.66) for ASCVD (4 studies; 71,526 individuals; 8,576 events), 1.62 (95% CI: 1.37-1.93) for ischemic heart disease (6 studies; 107,538 individuals; 9,734 events), 1.30 (95% CI: 1.13-1.49) for ischemic stroke (4 studies; 78,026 individuals; 4,273 events), and 1.53 (95% CI: 1.29-1.81) for peripheral artery disease (4 studies; 107,511 individuals; 1,848 events). Conclusions: Elevated LDL

Details

Database :
OAIster
Journal :
Balling , M , Afzal , S , Davey Smith , G , Varbo , A , Langsted , A , Kamstrup , P R & Nordestgaard , B G 2023 , ' Elevated LDL Triglycerides and Atherosclerotic Risk ' , Journal of the American College of Cardiology , vol. 81 , no. 2 , pp. 136-152 .
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1382516152
Document Type :
Electronic Resource